Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERGER F. M., DOUGLAS J. F., KLETZKIN M., LUDWIG B. J., MARGOLIN S. The pharmacological properties of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (Mebutamate, W-583), a new centrally acting blood pressure lowering agent. J Pharmacol Exp Ther. 1961 Dec;134:356–365. [PubMed] [Google Scholar]
- BODI T., LEVY H. A., NODINE J. H., MOYER J. H. The hypnotic effect of a new propanediol dicarbamate, W 583 (a double blind, double dose study). Am J Med Sci. 1960 Feb;239:207–212. doi: 10.1097/00000441-196002000-00015. [DOI] [PubMed] [Google Scholar]
- CORCORAN A. C., LOYKE H. F. Mebutamate as antihypertensive agent in hospital outpatients. JAMA. 1962 Sep 22;181:1043–1049. doi: 10.1001/jama.1962.03050380021006. [DOI] [PubMed] [Google Scholar]
- DUARTE C., BREST A. N., KODAMA R., NASO F., MOYER J. H. Observations on the antihypertensive effectiveness of a new propanediol dicarbamate (W-583). Curr Ther Res Clin Exp. 1960 May;2:148–152. [PubMed] [Google Scholar]
- KAVELMAN D. A., LEWIS J. A. CLINICAL EVALUATION OF A NEW ANTIHYPERTENSIVE AGENT: W583 (MEBUTAMATE). Can Med Assoc J. 1963 Nov 9;89:993–995. [PMC free article] [PubMed] [Google Scholar]
- PORTER G. A., BAIRD M. D., GRISWOLD H. E. Clinical observations on the antihypertensive response to mebutamate (Capla) in geriatric patients. Am Heart J. 1962 Jun;63:754–756. doi: 10.1016/0002-8703(62)90060-1. [DOI] [PubMed] [Google Scholar]